远大蜀阳生命科学（成都）有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
35
NMPA:35
Drug Approvals
Human Coagulation Factor Ⅸ
- Product Name
- 人凝血因子Ⅸ
- Approval Number
- 国药准字S20233098
- Approval Date
- Feb 14, 2023
NMPA
Human Hepatitis B Immunoglobulin（pH4）for Intravenous Injection
- Product Name
- 静注乙型肝炎人免疫球蛋白(pH4)
- Approval Number
- 国药准字S20083007
- Approval Date
- Apr 18, 2022
NMPA
Human Hepatitis B Immunoglobulin
- Product Name
- 乙型肝炎人免疫球蛋白
- Approval Number
- 国药准字S19993046
- Approval Date
- Mar 2, 2020
NMPA
Human Hepatitis B Immunoglobulin
- Product Name
- 乙型肝炎人免疫球蛋白
- Approval Number
- 国药准字S19993044
- Approval Date
- Mar 2, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found